Long Term Outcomes of OCT Guided PCI in STEMI patients

Prior studies have shown the use of optical coherence tomography (OCT) have a significant influence on decision making, optimizing PCI and improving outcomes, vs conventional PCI. However, these studies have focused mainly on patients with stable angina or non-ST elevation MI. 

Resultados a largo plazo de la utilización de OCT para guiar ATC en pacientes con IAMCEST

The aim of this retrospective study was to find out whether the use of OCT can reduce mortality at long term (5 years) vs. PCI alone in patients with ST elevation MI (STEMI). 

Primary end point was all-cause mortality rate, and secondary end point was cardiovascular mortality rate.

3,897 were enrolled: 69.2% were treated with OCT and 30.8% with PCI alone. Mean patient age was approximately 60, and most patients were men. Among OCT patients, the most affected artery was the anterior descending, while in the PCI alone group, it was the right coronary. 

OCT guided patients were treated with stents less frequently during PCI (62.6% vs 80.2%; p<0.001). At 5 years, accumulated all-cause mortality and cardiovascular rates in the OCT guided cohort were 10.4% and 8.0%, respectively, significantly lower than the PCI alone cohort (19.0% and 14.1%; p<0.001).

Read also: Definite Pacemaker Implantation Predictors in TAVR High Implant Using Cusp Overlap.

Multivariable models showed the use of OCT might significantly reduce all-cause mortality at 5 years (HR: 0.689, CI 95%: 0.551-0.862) and cardiovascular mortality (HR: 0.692, IC 95%: 0.536-0.895). After propensity score matching for homogenous samples, the benefits of OCT guided PCI remained consistent in terms of all-cause (HR: 0.707, CI 95%: 0.548-0.913) and cardiovascular mortality (HR: 0.709, CI 95%: 0.526-0.955).

Conclusion

In this observational study, the use of OCT during PCI in patients with STEMI was associated to reduced mortality at long term vs. PCI alone. However, we need prospective randomized studies to confirm these results. 

Original Title: Five-year follow-up of OCT-guided percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

Reference: Luping He, MD et al EuroIntervention 2024;20:e937-e947.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

 

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...